Future prospects for an Innovative Medicines Fund for England
NICE suggests interim CDF funding while further data is gathered.
Only five drugs left to assess from old scheme.
How do the countries of the UK fund cancer drugs today, and do they have the right approaches?
Lilly’s drug will be re-appraised in 2020